| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.006 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.007 |